Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials
Pharmacogenetics and biomarkers are becoming normalised as important technologies to improve drug efficacy rates, reduce the incidence of adverse drug reactions, and make informed choices for...
pmc.ncbi.nlm.nih.gov